Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.
Type:
Grant
Filed:
March 8, 2018
Date of Patent:
August 27, 2019
Assignee:
Arbor Biotechnologies, Inc.
Inventors:
David R. Cheng, David A. Scott, Winston X. Yan, Shaorong Chong